Press Releases

Date

Title

View

28 May 19

Expedeon AG: Expedeon AG adds CaptSure DIY ELISA to immunoassay technology product range (news with additional features)

View View

14 May 19

Expedeon AG: Expedeon to Present at the Frankfurt Spring Conference (news with additional features)

View View

09 May 19

Expedeon AG: Expedeon reports first quarter 2019 financial results (news with additional features)

View View

08 May 19

Expedeon AG: Expedeon AG adds ELISA-ONE(TM) next generation cell signalling assay technology to product offering (news with additional features)

View View

25 Apr 19

Expedeon AG: Expedeon Reports Financial Results for Fiscal Year 2018 – Financial Guidance Met (news with additional features)

View View

14 Mar 19

Expedeon AG: Expedeon Announces Supervisory Board Changes (news with additional features)

View View

08 Jan 19

Expedeon AG licenses Lightning-Link(R) Rapid Biotinylation technology to Cell Guidance Systems in supply agreement (news with additional features)

View View

08 Nov 18

Expedeon AG reports strong third quarter 2018 financial results (news with additional features)

View View

07 Nov 18

Expedeon AG signs supply and license agreement with Quanterix Corporation for access to proprietary immunoassay technology (news with additional features)

View View

27 Sep 18

Expedeon AG signs supply agreement with Reszon Diagnostics for proprietary colloidal gold technology (news with additional features)

View View

18 Sep 18

Expedeon AG comments on recent share price development (news with additional features)

View View

11 Sep 18

Expedeon AG announces commercial-use licence of proprietary technology in diagnostic assay (news with additional features)

View View